July 8, 2010 – The Canadian Nuclear Safety Commission (CNSC) announced this week it has authorized the reactivation of the National Research Universal (NRU) reactor in Chalk River, Ontario, Canada. It is estimated that NRU will resume medical isotope production by the end of July, after being shut down in 2009 for several repairs.

The Atomic Energy of Canada Limited (AECL) appeared before the Canadian Nuclear Safety Commission (CNSC) on July 5 in a public hearing to consider AECL’s application to restart the reactor. During the hearing, AECL presented its case on NRU’s readiness to resume safe operation and the path forward for planned operation and maintenance of the reactor. Progress is being made on completing the many tests, system configurations and tasks required prior to actual restart of NRU. These activities will continue over the next few weeks.

The reactor produces most of the medical isotopes for Canada and the United States. The reactor produces molybdenum-99 (Mo-99), used to produce technetium-99 used in diagnostic nuclear imaging scans.


Additional Content

News | Molecular Imaging

Editor's Note: This article has been updated to correct an earlier version. Oct. 15, 2026 — GE HealthCare has announced ...

Time October 16, 2026
arrow
News | Radiation Oncology

Oct. 12, 2026 — RWJBarnabas Health and Rutgers Cancer Institute have earned a systemwide accreditation from the American ...

Time October 13, 2026
arrow
News | Radiopharmaceuticals and Tracers

Oct. 5, 2026 — GE HealthCare has announced a definitive agreement to acquire SOFIE Biosciences, a U.S.-based CMO for PET ...

Time October 06, 2026
arrow
News | PET Imaging

Sept. 22, 2026 — Researchers from the Keck School of Medicine of USC are developing a new “plug-and-play” platform that ...

Time September 23, 2026
arrow
News | Women's Health

Sept. 1, 2026 — On Sept. 24, 2026 at 1 p.m. EDT, Siemens Healthineers will present a webinar on "Advancing Women's ...

Time September 03, 2026
arrow
Subscribe Now